Analytical Data
-
Gene name
CCNT1
- Application
-
Alternative Names
Cyclin-T1; CCNT1; Homo sapiens; Human; Cyclin
-
Species
Human
-
Source
E. coli
-
Tag
Tag Free
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O60563-1
-
Expression Region
M1-R259
-
Protein Length
Partial
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CCNT1 (cyclin C-associated kinase 1) is a member of the cyclin-dependent kinase family, playing a pivotal role in the regulation of the cell cycle and transcription. Understanding CCNT1's function and regulation is critical, as alterations in its activity are implicated in various cancers and developmental disorders. Research into CCNT1 recombinant protein focuses on its biochemical properties, interaction with other cellular components, and its role in both normal and pathological processes. The production of CCNT1 as a recombinant protein allows for detailed studies of its functional mechanisms, including kinase activity and interaction with cyclins and other regulatory proteins. This research is essential for developing therapeutic strategies targeting aberrant CCNT1 functions in diseases. Additionally, characterizing the structural and functional properties of CCNT1 can provide insights into its potential as a biomarker for disease progression and treatment response. Overall, CCNT1 recombinant protein studies contribute to a broader understanding of cell cycle regulation and highlight the importance of targeted research in elucidating the molecular underpinnings of cancer and other disorders.
